Literature DB >> 12615079

Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells.

Minghao Zhong1, Yingjie Shen, Yang Zheng, Troy Joseph, Desmond Jackson, David A Foster.   

Abstract

Phospholipase D (PLD) activity is elevated in response to mitogenic and oncogenic signals. PLD also cooperates with overexpressed tyrosine kinases to transform rat fibroblasts. 3Y1 rat fibroblasts overexpressing the tyrosine kinase c-Src undergo apoptosis in response to serum withdrawal. We report here that elevated expression of either PLD1 or PLD2 in these cells prevents apoptosis induced by serum withdrawal. 3Y1 cells transformed by the activated tyrosine kinase v-Src have elevated PLD activity and are resistant to apoptosis induced by serum withdrawal. However, if PLD activity is blocked, the v-Src-transformed cells underwent apoptosis. MDA-MB-231 cells are a human breast cancer cell line with substantially elevated levels of PLD activity. Inhibiting PLD activity in these cells similarly rendered them sensitive to the apoptotic insult of serum withdrawal. These data indicate that elevated PLD activity generates a survival signal(s) allowing cells to overcome default apoptosis programs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615079     DOI: 10.1016/s0006-291x(03)00229-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.

Authors:  Karen M Henkels; Hong-Juan Peng; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 2.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

Review 3.  The Enigma of Rapamycin Dosage.

Authors:  Suman Mukhopadhyay; Maria A Frias; Amrita Chatterjee; Paige Yellen; David A Foster
Journal:  Mol Cancer Ther       Date:  2016-02-25       Impact factor: 6.261

Review 4.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

5.  Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.

Authors:  Vanessa Rodrik; Yang Zheng; Faith Harrow; Yuhong Chen; David A Foster
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.

Authors:  Mayur Gadiya; Noriko Mori; Maria D Cao; Yelena Mironchik; Samata Kakkad; Ingrid S Gribbestad; Kristine Glunde; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

Review 7.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells.

Authors:  Xin Chen; Li Hui; David A Foster; Charles Michael Drain
Journal:  Biochemistry       Date:  2004-08-31       Impact factor: 3.162

9.  Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway.

Authors:  Maoxi Liu; Zhongxue Fu; Xingye Wu; Kunli Du; Shouru Zhang; Li Zeng
Journal:  Tumour Biol       Date:  2015-11-27

Review 10.  Cellular and physiological roles for phospholipase D1 in cancer.

Authors:  Yi Zhang; Michael A Frohman
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.